Avingtrans results were slightly ahead of our expectations, a good out-turn in a challenging year. Growth has been driven across a number of Energy operations. Metalcraft going into phase 2 of 3M3 boxes for Sellafield, Hayward Tyler and Energy Steel in nuclear bids and Booth with HS2. Medical has made good progress with Adaptix products gaining FDA approval and Magnetica on plan. Adaptix is now fully owned. FY24 has started well supported by a decent order book and trading in-line with expectati ....
